- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 122.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 122.46M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $26.06M |
| Capex | Q1 2026 · Mar 31, 2025 | $81.57M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $81.74M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $24.81M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.21M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $6.44M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $720.7M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $699.69M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.3B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.15B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $702.82M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $687.47M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.84B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.86B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$4.06 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$4.06 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $17.52M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $40.64M |
| Net Income | Q1 2026 · Mar 31, 2026 | $6.8M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$469.08M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $76.61M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $21.97M |
| Revenue | Q1 2026 · Mar 31, 2026 | $446.56M |
| Revenue | Q1 2026 · Mar 31, 2025 | $398.31M |